ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,847Top JournalGold OA

Cancer Cell International

Abbreviation (ISO):CANCER CELL INT
•
Identifier (ISSN):1475-2867(Print)
•
Publisher:BioMed Central
Clarivate IF (2026)
7↑ +1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Cell International

WoS Q1
24793.9620183.4420194.1720205.7220216.4320225.820235.320246202572026
Annual Impact Factor Metric
Current (2026):7
Scopus SJR & RankScopus Q1
1.75
#1,847

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
100

100 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
670articles/year
100% Gold OA•69.25% Original Research

Aims & Scope

Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques. The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments). These types of experiments have provided crucial data in many fields, from cell proliferation and transformation, to epithelial-mesenchymal interaction, to apoptosis, and host immune response to tumors. Cancer Cell International also considers articles that focus on novel technologies or novel pathways in molecular analysis and on epidemiological studies that may affect patient care, as well as articles reporting translational cancer research studies where in vitro discoveries are bridged to the clinic. As such, the journal is interested in laboratory and animal studies reporting on novel biomarkers of tumor progression and response to therapy and on their applicability to human cancers.

Topics Covered (Recognized by AI)
Biology99%Genetics98.1%Medicine98.1%Chemistry91.4%Biochemistry90.9%Internal medicine90.4%Cancer research82.7%Cancer75.2%Gene74.5%Apoptosis44.8%Immunology41.2%Pathology40.8%Cell biology38.9%Cell culture38.6%Cell35.7%Cell growth28.7%Oncology26.6%In vitro25.5%Molecular biology22.9%Downregulation and upregulation21.4%Surgery20.6%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank54/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank67/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF7
Articles / Year329
Total Citations196
2025
IF6
Articles / Year499
Total Citations2,525
2024
IF5.3
Articles / Year438
Total Citations5,274
2023
IF5.8
Articles / Year335
Total Citations6,676
2022
IF6.429
Articles / Year423
Total Citations11,792

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,847Scopus Q1SCImago Profile
Scopus Coverage:2001-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.75

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.89

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,519 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations8,157
3-Year Documents1,132
Citable Documents1,131

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

GeneticsQ1
OncologyQ1
Cancer ResearchQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
In warning list
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Cell International (abbr: CANCER CELL INT, ISSN: 1475-2867) is a peer-reviewed international scholarly journal in the field of ONCOLOGY, published by BioMed Central in England since 2001. The periodical holds a Journal Impact Factor (JIF) of 7.00, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.750 (Q1), an H-index of 100.

The journal enforces rigorous peer evaluation with a publication frequency of Irregular, an annual output of approximately 670 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,519 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
BioMed Central
Publication Language
English
Frequency
Irregular
Founding Year
2001
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 8f2bd7df-2cf3-4c81-8311-fa8b84c85d9e
Database Updated: 2026-10-01